A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial

OBJECTIVES: Peptides delivered on the surface of influenza virosomes have been shown to induce solid humoral immune responses in experimental animals. High titers of peptide-specific antibodies were also induced in a phase 1a clinical trial in volunteers immunized with virosomal formulations of two...

Descripción completa

Detalles Bibliográficos
Autores principales: Okitsu, Shinji L., Silvie, Olivier, Westerfeld, Nicole, Curcic, Marija, Kammer, Andreas R., Mueller, Markus S., Sauerwein, Robert W., Robinson, John A., Genton, Blaise, Mazier, Dominique, Zurbriggen, Rinaldo, Pluschke, Gerd
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2093993/
https://www.ncbi.nlm.nih.gov/pubmed/18060072
http://dx.doi.org/10.1371/journal.pone.0001278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2093993/
https://www.ncbi.nlm.nih.gov/pubmed/18060072
http://dx.doi.org/10.1371/journal.pone.0001278

Ejemplares similares